Texts that could transform trans teen sexual health
NCT ID NCT07681908
First seen Jul 02, 2026 · Last updated Jul 02, 2026
Summary
This study tests a 5-month text-messaging program called #TranscendentHealth, created specifically for transgender boys and gender-diverse youth assigned female at birth, ages 14 to 18. The program aims to improve condom use, birth control use, and HIV/STI testing by addressing the unique needs and experiences of these teens. Participants are randomly assigned to receive either the tailored program or a general sexual health text program, and complete surveys over about a year.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
#TranscendentHealth text messaging program
What this could lead to
If effective, this could provide a scalable, private way to improve sexual health and reduce unintended pregnancy among transgender and gender-diverse youth.
What could go wrong
This is an early-stage adaptation of an existing program, and its success depends on whether the tailored content engages participants better than a general program. Results may not apply to all youth.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Foscenvivint for Liver Cirrhosis in HIV/HCV & He NCT07681089
- RSV Vaccine Trial for Pregnant Women with HIV (NCT06325657)
- Smoking Cessation App for Black Smokers with HIV NCT05709002
- HIV and Cerebral Small Vessel Disease Study NCT02210130
- Urine HPV Test for Cervical Cancer Screening (NCT05413798)
- Cervical Cancer Screening in Ethiopia: HPV Self- NCT07678047
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Center for Innovative Public Health Research (CiPHR)
San Clemente, California, 92672, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••